WASHINGTON, Jan. 11 Danaher Corporation (NYSE: DHR) announced today that it has acquired and received acceptances in respect of approximately 97% of the currently issued shares of Genetix Group plc (GTX: AIM) in relation to its previously announced offer dated December 18, 2009.
Danaher intends to acquire any common shares of Genetix that remain untendered through the compulsory acquisition provisions of the applicable UK companies legislation.
Danaher (NYSE: DHR), based in Washington. D.C., is a diversified technology leader that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. Our portfolio of premier brands is among the most highly recognized in each of the markets we serve. Driven by the Danaher Business System, our 50,000 associates serve customers in more than 125 countries and generated $12.7 billion of revenue in 2008. For more information please visit our website: www.danaher.com.
Statements in this document that are not strictly historical, including statements regarding the acquisition of the untendered shares, may constitute forward looking statements. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements. Information regarding factors that may cause actual results to differ materially from these forward-looking statements is available in Danaher's SEC filings, including Danaher's 2008 Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the quarter ended October 2, 2009. These forward-looking statements speak only as of the date of this release and Danaher does not assume any obligation to update any forward-looking statement.
SOURCE Danaher Corporation